GUD.TO vs. WN.TO
GUD.TO (Knight Therapeutics Inc.) and WN.TO (George Weston Limited) are both stocks. GUD.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare), while WN.TO operates in Grocery Stores (Consumer Defensive). Over the past 10 years, GUD.TO returned -0.02%/yr vs 12.02%/yr for WN.TO. At a 0.14 correlation, their price movements are largely independent.
Performance
GUD.TO vs. WN.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GUD.TO achieves a 39.83% return, which is significantly higher than WN.TO's 5.61% return. Over the past 10 years, GUD.TO has underperformed WN.TO with an annualized return of -0.02%, while WN.TO has yielded a comparatively higher 12.02% annualized return.
GUD.TO
- 1D
- 1.81%
- 1M
- 12.05%
- YTD
- 39.83%
- 6M
- 39.83%
- 1Y
- 45.36%
- 3Y*
- 20.13%
- 5Y*
- 9.97%
- 10Y*
- -0.02%
WN.TO
- 1D
- 0.77%
- 1M
- 1.42%
- YTD
- 5.61%
- 6M
- 4.66%
- 1Y
- 12.51%
- 3Y*
- 26.08%
- 5Y*
- 22.19%
- 10Y*
- 12.02%
GUD.TO vs. WN.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GUD.TO Knight Therapeutics Inc. | 39.83% | 13.30% | 2.89% | 0.19% | -2.26% | -0.93% | -29.42% | -1.43% | -7.46% | -22.63% |
WN.TO George Weston Limited | 5.61% | 28.81% | 37.98% | -0.33% | 16.43% | 57.16% | -5.66% | 16.76% | -15.87% | -2.34% |
Correlation
The correlation between GUD.TO and WN.TO is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2014 | 0.14 |
Fundamentals
GUD.TO:
CA$836.92M
WN.TO:
CA$37.90B
GUD.TO:
CA$0.06
WN.TO:
CA$4.55
GUD.TO:
149.82
WN.TO:
21.91
GUD.TO:
1.65
WN.TO:
0.39
GUD.TO:
1.06
WN.TO:
9.34
GUD.TO:
CA$510.45M
WN.TO:
CA$64.87B
GUD.TO:
CA$190.52M
WN.TO:
CA$20.58B
GUD.TO:
CA$65.18M
WN.TO:
CA$7.04B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GUD.TO vs. WN.TO — Risk / Return Rank
GUD.TO
WN.TO
GUD.TO vs. WN.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Knight Therapeutics Inc. (GUD.TO) and George Weston Limited (WN.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GUD.TO | WN.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.26 | ||
| Sortino ratioReturn per unit of downside risk | +2.30 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.12 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 3.77 | 1.37 | +2.40 |
| Martin ratioReturn relative to average drawdown | 7.21 | 2.78 | +4.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GUD.TO | WN.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.89 | 0.63 | +1.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 1.19 | -0.77 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.00 | 0.64 | -0.64 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.48 | -0.24 |
Drawdowns
GUD.TO vs. WN.TO - Drawdown Comparison
The maximum GUD.TO drawdown since its inception was -60.09%, smaller than the maximum WN.TO drawdown of -64.22%. Use the drawdown chart below to compare losses from any high point for GUD.TO and WN.TO.
Loading charts...
Drawdown Indicators
| GUD.TO | WN.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.09% | -64.22% | +4.13% |
Max Drawdown (1Y)Largest decline over 1 year | -12.08% | -9.15% | -2.93% |
Max Drawdown (3Y)Largest decline over 3 years | -17.58% | -10.33% | -7.25% |
Max Drawdown (5Y)Largest decline over 5 years | -29.61% | -19.57% | -10.04% |
Max Drawdown (10Y)Largest decline over 10 years | -60.09% | -27.71% | -32.38% |
Current DrawdownCurrent decline from peak | -22.39% | -2.92% | -19.47% |
Average DrawdownAverage peak-to-trough decline | -34.48% | -16.97% | -17.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.31% | 4.51% | +1.80% |
Volatility
GUD.TO vs. WN.TO - Volatility Comparison
Knight Therapeutics Inc. (GUD.TO) has a higher volatility of 13.21% compared to George Weston Limited (WN.TO) at 7.09%. This indicates that GUD.TO's price experiences larger fluctuations and is considered to be riskier than WN.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GUD.TO | WN.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.21% | 7.09% | +6.12% |
Volatility (6M)Calculated over the trailing 6-month period | 19.97% | 14.39% | +5.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.06% | 19.98% | +4.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.05% | 18.80% | +5.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.08% | 18.95% | +5.13% |
Dividends
GUD.TO vs. WN.TO - Dividend Comparison
GUD.TO has not paid dividends to shareholders, while WN.TO's dividend yield for the trailing twelve months is around 1.20%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GUD.TO Knight Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WN.TO George Weston Limited | 1.20% | 1.23% | 1.42% | 1.70% | 1.54% | 1.57% | 2.23% | 2.03% | 2.17% | 1.65% | 1.54% | 1.59% |
Financials
GUD.TO vs. WN.TO - Financials Comparison
This section allows you to compare key financial metrics between Knight Therapeutics Inc. and George Weston Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GUD.TO vs. WN.TO - Profitability Comparison
GUD.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Knight Therapeutics Inc. reported a gross profit of 54.44M and revenue of 148.44M. Therefore, the gross margin over that period was 36.7%.
WN.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, George Weston Limited reported a gross profit of 4.70B and revenue of 14.64B. Therefore, the gross margin over that period was 32.1%.
GUD.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Knight Therapeutics Inc. reported an operating income of 10.58M and revenue of 148.44M, resulting in an operating margin of 7.1%.
WN.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, George Weston Limited reported an operating income of 1.35B and revenue of 14.64B, resulting in an operating margin of 9.2%.
GUD.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Knight Therapeutics Inc. reported a net income of 13.17M and revenue of 148.44M, resulting in a net margin of 8.9%.
WN.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, George Weston Limited reported a net income of 116.00M and revenue of 14.64B, resulting in a net margin of 0.8%.
Frequently Asked Questions
GUD.TO and WN.TO have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GUD.TO and WN.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer